• HOME
  • ABOUT US
  • TECHNOLOGY
  • NEWS
  • SERVICES
    • RESEARCH AND DEVELOPMENT
  • PRODUCTS
    • My account
    • Cart
  • CONTACT
Type and hit ENTER
  • HOME
  • ABOUT US
  • TECHNOLOGY
  • NEWS
  • SERVICES
    • RESEARCH AND DEVELOPMENT
  • PRODUCTS
    • My account
    • Cart
  • CONTACT
GET CONNECTED
  • HOME
  • ABOUT US
  • TECHNOLOGY
  • NEWS
  • SERVICES
    • RESEARCH AND DEVELOPMENT
  • PRODUCTS
    • My account
    • Cart
  • CONTACT
ProAxsis builds market presence
Share
News

ProAxsis builds market presence

June 20, 2016
-
Posted by Webmaster

ProAxsis (www.proaxsis.com) is undertaking business development activities with Invest Northern Ireland support. Speaking about the plans, Dr David Ribeiro, CEO of ProAxsis, said: “This funding will allow us to complete further commercial activities concerning the development of our point-of-care test, for detecting neutrophil elastase as a biomarker of infection and inflammation in patients with chronic respiratory diseases such as COPD and cystic fibrosis. Invest NI is a fantastic supporter of innovative companies based in Northern Ireland, and we’re very grateful for their continuing support.”
Invest NI has offered ProAxsis £48,000 to support its market development activities.

Ian Murphy, Invest NI’s Director of Growth and Scaling, added: “ProAxsis is a highly innovative University spinout focused on growing its customer base outside Northern Ireland. Invest NI’s support is helping the business gain greater insight into the potential business opportunities for its medical technology so that it can reach its export potential.”

Any queries concerning ProAxsis’ Immunoassays for measuring active neutrophil elastase and active Cathepsin G, or any other aspects of the company’s proprietary ProteaseTag® technology, can be directed to info@77.104.171.207. For further information about Invest Northern Ireland, please visit www.investni.com

ProAxsis is part of the NetScientific group and is one of the group’s core portfolio companies. The company is also supported by QUBIS, the commercialisation arm of Queens University.

June 20, 2016

Related News

Other posts that you should not miss.
Announcements, News, ProteaseTag®

ProAxsis successfully licenses additional intellectual property from The Queen’s University of Belfast

May 10, 2017
-
Posted by Webmaster

ProAxsis Limited (www.proaxsis.com) is delighted to announce that it has secured a second licensing agreement with the Queen’s …

Read More
May 10, 2017
Posted by Webmaster
News, ProteaseTag®

ProAxsis gains backing of Innovate UK

January 25, 2017
-
Posted by Webmaster

ProAxsis Limited (www.proaxsis.com) is further expanding its ProteaseTag® technology platform, via a project co-funded by the UK’s innovation …

Read More
January 25, 2017
Posted by Webmaster
News

ProAxsis shortlisted for Small Business of the Year Award

November 18, 2019
-
Posted by David Ribeiro

ProAxsis is delighted to have been shortlisted for a Business Eye First Trust Award for the second …

Read More
November 18, 2019
Posted by David Ribeiro
← PREVIOUS POST
ProAxsis featured in Business Eye
NEXT POST →
ProAxsis team to attend BIO 2016
Categories
  • Announcements
  • Conferences
  • NEATstik®
  • Neutrophil Elastase Immunoassay
  • News
  • ProteaseTag®
  • Trials
  • Video
GET CONNECTED
RECENT POSTS
  • ProAxsis supports next generation of scientists
    October 25, 2019

    ProAxsis was delighted to support the recent School of Pharmacy Undergraduate Awards at Queen’s …

  • ProAxsis welcomes Professor Stephen Smith as new Chairman
    October 25, 2019

    ProAxsis is pleased to confirm that Professor Stephen Smith has become the Chairman …

  • New data demonstrates high potential of NEATstik® as a rapid point-of-care monitoring tool for lung diseases
    June 3, 2019

    Positive early data from the BRIDGE1 study, a three-year 1000+ patient study in …


ProAxsis Ltd
Unit 1B, Concourse Building 3,
Catalyst Inc,
Queen’s Road, Titanic Quarter,
Belfast,
BT3 9DT,
Northern Ireland

tel +44 (0)28 9073 0444
email info@proaxsis.com

RECENT NEWS
  • November 18, 2019
    ProAxsis shortlisted for Small Business of the Year Award
  • October 25, 2019
    ProAxsis supports next generation of scientists
  • October 25, 2019
    ProAxsis welcomes Professor Stephen Smith as new Chairman
LATEST TWEETS
Twitter
ProAxsis
Follow Me
@TimFerguson01 https://t.co/00k2mJHY4o
8 days ago
- ProAxsis
Having a great night and delighted to be shortlisted at the #AIBBEawards @eye_business
8 days ago
- ProAxsis
RT @geinarsson: Recommended preprint by Alison Dicker et al. from @ProfJDChalmers group in Dundee on "The Sputum Microbiome Is Associated w…
24 days ago
- ProAxsis
RT @ProfJDChalmers: In summary- lower microbiome diversity means more exacerbations, more lung inflammation and a higher risk of mortality…
25 days ago
- ProAxsis
Copyright © 2016-2018 - ProAxsis - All rights reserved. 
ProAxsis builds market presence | ProAxsis